With six approved drugs, namely POLIVY™, LUMOXITI™, BESPONSA®, MYLOTARG™, KADCYLA®, ADCETRIS® and over 300 drugs underdevelopment, antibody drug conjugates ...
R A
Bispecific antibody therapeutics represent a transformative approach to modern treatment; over the years, this upcoming class of ‘two-target’ artificially ...
Recent advances in molecular biology have enabled researchers to develop a better understanding of the rare soft tissue sarcomas; as a result, a number of ...
Roots Analysis is pleased to announce the publication of its recent study, titled, “Synthetic Lethality-based Drugs and Targets Market, 2019-2030: Focus on DNA ...
In addition to enhancing physiochemical characteristics of drugs, nanoparticles act as drug delivery systems; given their crucial role in development of ...
Extensive research on cell encapsulation strategies has enabled the development of a variety of technologies capable of immobilizing / enclosing therapeutic ...
The proteome profiling services market is projected to grow at an annualized rate of ~15%, till 2030
To order this detailed 290+ page report, please visit this - https://www.rootsanalysis.com/reports/proteome-profiling-services.html Key Inclusions ...
To order this detailed 210+ page report, please visit https://www.rootsanalysis.com/reports/pharmaceutical-secondary-packaging-market.html Key ...
Human factors engineering and usability testing have now become an essential part of product design across almost all industries, offering developers the ...
Given the potential of myeloid cells targeting therapies to treat multiple oncological and non-oncological disorders, such therapies have generated significant ...
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 39
- Next Page »